Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
A small percentage have had vision problems, but a direct causal link with the drugs has not been established.
Meanwhile, Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used ... Tirzepatide (Mounjaro brand) is used for type 2 diabetes to help improve ...
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...
WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests.  The active drug ...
Mounjaro is one brand name for the drug tirzepatide from the pharmaceutical manufacturer Eli Lilly. It’s also FDA-approved to help those with type 2 diabetes manage blood sugar and prescribed ...
An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Many providers have begun to switch patients from tirzepatide to semaglutide or, when they can afford it, to the brand-name drug. The telehealth company Ro, which in the past offered compounded ...
Angie from Milwaukee Medical Weight Loss & Medispa is here today to chat about how weight loss injectables are a game changer for people and her practice.